ABN AMRO Investment Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58M | Sell |
130,291
-7,351
| -5% | -$3.27M | 1.16% | 24 |
|
|
2025
Q1 | $66.7M | Sell |
137,642
-2,595
| -2% | -$1.26M | 1.39% | 18 |
|
|
2024
Q4 | $56.5M | Buy |
140,237
+130,033
| +1,274% | +$52.4M | 1.05% | 25 |
|
|
2024
Q3 | $4.75M | Sell |
10,204
-3,424
| -25% | -$1.59M | 0.08% | 163 |
|
|
2024
Q2 | $6.39M | Sell |
13,628
-2,106
| -13% | -$987K | 0.12% | 132 |
|
|
2024
Q1 | $6.58M | Sell |
15,734
-10,950
| -41% | -$4.58M | 0.11% | 133 |
|
|
2023
Q4 | $10.9M | Sell |
26,684
-1,791
| -6% | -$729K | 0.19% | 102 |
|
|
2023
Q3 | $9.9M | Sell |
28,475
-1,387
| -5% | -$482K | 0.19% | 107 |
|
|
2023
Q2 | $10.5M | Sell |
29,862
-5,337
| -15% | -$1.88M | 0.21% | 106 |
|
|
2023
Q1 | $11.1M | Buy |
+35,199
| New | +$11.1M | 0.23% | 105 |
|